why choose us

First received: October 08, 2023

Clinical Trial: TGRX-678 US Phase I for Subjects With Refractory or Advanced Chronic Myelogenous Leukemia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Chronic Myelogenous Leukemia

Study Type: INTERVENTIONAL


Official Title: A Single-arm, Open-label, Dose Escalation + Cohort Expansion Phase 1 Trial on Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TGRX-678 in Subjects With Refractory or Advanced Chroni

Brief Summary: The purpose of this single-arm, open-label, dose escalation + cohort expansion study is to evaluate the safety, tolerability, pharmacokinetic and preliminary efficacy of TGRX-678 in Chronic Myelogenous Leukemia patients who had failure with or are intolerant to TKI treatments.

Read more